What it sells
We built the world's first automated digital pathology lab.
Business model breakdown
Buyer: who owns the budget?
UnverifiedPathology lab directors and research/clinical teams.
Trigger: what makes them buy now?
UnverifiedNeed faster fresh-tissue imaging without cutting/fixing that wastes tissue or delays results.
Workflow: what inputs become what output?
Load fresh tissue in a sample holder, Nova images the whole sample in minutes, review digitally on a workstation, and the same tissue is preserved for downstream testing.
Economics: what it saves and how it charges
UnverifiedSells Nova imaging system (Class I medical device); price not stated, likely instrument sale or lease plus service.
Distribution: how it reaches customers
Demo-led direct sales ("Schedule a Demo") to clinical and research labs.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2019 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.